Association between TNF-α −308G/A polymorphism and diabetic nephropathy risk: a meta-analysis
- 341 Downloads
TNF-α −308G/A polymorphism has been implicated in the susceptibility of diabetic nephropathy, but studies have reported inconclusive results. The present study investigated the relationship between −308G/A polymorphism in the TNF-α gene and diabetic nephropathy risk by meta-analysis.
Data from PubMed, Embase, Ovid, Cochrane Library, China National Knowledge Infrastructure, Wanfang, VIP and China Biology Medicine disc databases were evaluated and analyzed. Statistical analysis was performed using RevMan 4.2 and Stata 10.0 software.
A total of 1,277 diabetic nephropathy cases and 1,740 controls in eight case-controlled studies were identified for data analysis. The results suggested that A allele carriers (GA + AA) may not have an altered risk of diabetic nephropathy when compared with homozygote GG carriers with boarder-line statistical significance (OR = 0.84, 95 % CI = 0.71–1.00, p = 0.05 for GA + AA vs. GG). However, in Asian subgroup analysis, the A allele variant was associated with a decreased diabetic nephropathy risk (OR = 0.69, 95 % CI = 0.51–0.94, p = 0.02 for GA + AA vs. GG).
Meta-analysis suggests that the A allele of TNF-α −308G/A polymorphism might be protective against diabetic nephropathy with ethnic selectivity. Future studies are needed to validate these findings.
KeywordsTNF-α −308G/A polymorphism Gene Diabetic nephropathy Meta-analysis
Conflict of interest
The authors declare that they have no conflict of interest.
- 5.El-Sherbini SM, Shahen SM, Mosaad YM, Abdelgawad MS, Talaat RM (2013) Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy. Acta Biochim Biophys Sin 45(4):330–338Google Scholar
- 6.Kurashige M, Imamura M, Araki S, Suzuki D, Babazono T, Uzu T, Umezono T, Toyoda M, Kawai K, Imanishi M (2013) The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes. PLoS ONE 8(1):e54064PubMedCrossRefGoogle Scholar
- 7.Lee IS, Lee JH, Kim HJ, Lee JM, Lee SK, Kim HS, Lee JM, Park KS, Ku BJ (2013) Novel ERBB receptor feedback inhibitor 1 (ERRFI1) +808 T/G polymorphism confers protective effect on diabetic nephropathy in a Korean population. Dis MarkersGoogle Scholar
- 10.Chang WT, Wang YC, Chen CC, Zhang SK, Liu CH, Chang FH, Hsu LS (2012) The −308G/A of Tumor Necrosis Factor (TNF)-α and 825C/T of Guanidine Nucleotide Binding Protein 3 (GNB3) are Associated with the Onset of Acute Myocardial Infarction and Obesity in Taiwan. Int J Mol Sci 13(2):1846–1857PubMedCrossRefGoogle Scholar
- 11.Guzmán-Flores JM, Escalante M, Sánchez-Corona J, García-Zapién AG, Cruz-Quevedo EG, Muñoz-Valle JF, Moran-Moguel MC, Saldaña-Cruz AM, Flores-Martínez SE (2013) Association analysis between −308G/A and −238G/A TNF-alpha gene promoter polymorphisms and insulin resistance in Mexican women with gestational diabetes mellitus. J Investig Med 61(2):265–269PubMedGoogle Scholar
- 13.Wang Y, Wu CX, Tang JY, Chen ZE (2008) Relationship between tumor necrosis factor-α G-308A gene polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients. Biao Ji Mian Yi Fen Xi Yu Lin Chuang (Chinese) 4(15):71–75Google Scholar
- 17.Krayenbuehl PA, Wiesli P, Schmid M, Schmid C, Ehses JA, Hersberger M, Vetter W, Schulthess G (2007) TNF-alpha −308G >A polymorphism modulates cytokine serum concentrations and macrovascular complications in diabetic patients on aspirin. Exp Clin Endocrinol Diabetes 115(5):322–326PubMedCrossRefGoogle Scholar
- 20.Okada H, Fukui M, Tanaka M, Matsumoto S, Mineoka Y, Nakanishi N, Asano M, Yamazaki M, Hasegawa G, Nakamura N (2013) Visit-to-Visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with Type 2 diabetes. Diabetes careGoogle Scholar